CJC-1295 (Without DAC) – 5 mL + IPA 5 mL
CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.
In research environments, CJC-1295 (Without DAC) is studied for its selective interaction with GHRH receptors located in the pituitary axis. These receptors regulate pulsatile growth hormone signaling, making the peptide valuable for examining natural hormone rhythm and feedback mechanisms.
One of the defining characteristics of CJC-1295 without DAC is its rapid clearance compared to long-acting analogs. This allows researchers to investigate acute signaling responses and short-term endocrine dynamics rather than sustained hormonal elevation.
CJC-1295 (Without DAC) is frequently included in studies focused on growth hormone pulse timing and amplitude. Understanding how brief receptor activation influences downstream signaling is a key area of interest in endocrine research.
The peptide is also examined in metabolic signaling research. Growth hormone pathways are closely tied to lipid utilization, protein metabolism, and energy balance, making CJC-1295 relevant for controlled metabolic studies.
Unlike direct growth hormone analogs, CJC-1295 works by stimulating endogenous signaling pathways rather than replacing the hormone itself. This distinction allows researchers to study physiological regulation while maintaining natural feedback loops.
Researchers often use the non-DAC form to compare signaling differences between short-acting and long-acting GHRH analogs. These comparisons help clarify how peptide structure influences duration and intensity of receptor activation.
CJC-1295 (Without DAC) is also studied in gene expression research, where growth hormone–related transcriptional changes are examined following transient signaling events.
The inclusion of IPA (Isopropyl Alcohol) in research kits supports laboratory handling and preparation protocols under controlled conditions. Its presence is intended strictly for research and laboratory use.
The peptide’s predictable molecular behavior supports reproducibility in experimental settings. Consistent receptor interaction allows for reliable comparison across studies.
CJC-1295 (Without DAC) is commonly included in endocrine research that prioritizes physiological accuracy over prolonged stimulation. This makes it useful for studies focused on natural hormonal signaling patterns.
Because growth hormone signaling affects multiple tissues, the peptide is often used in systems-based research rather than isolated pathway analysis.
Its well-characterized structure and short-acting profile make CJC-1295 (Without DAC) a valuable reference compound in growth hormone research.
As interest in peptide-based endocrine investigation continues to expand, CJC-1295 (Without DAC) remains an important tool for studying regulated growth hormone signaling within complex biological systems.
New
CJC-1295 without DAC 5ml + IPA 5ml
$90.00
CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.
Description
Shipping & Delivery
Related products
BPC 157 500mcg (60 Capsules)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
BPC-157, TB-500, GHK-Cu (Glow Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. 
GHK-Cu 50mg Copper Peptide
GHK-Cu is a small, naturally occurring peptide with the ability to attenuate inflammation, improve antioxidant responses, and improve gene expression on a large scale. Research shows that this copper-chelating peptide may be of critical importance both in the prevention of neurodegenerative disease and as a tool for exploring pathophysiological mechanisms. Studies in mice have revealed that GHK-Cu can protect against neurological insults, improve wound healing, reduce rates of infection, and boost blood vessel growth. The peptide has been of interest in recent years for its anti-oxidant properties that, in combination with its ability to alter gene expression patterns, appear to help slow or even reverse some aspects of aging.
Melanotan 2 (MT2) (3mg x 10 Vials = 30mg)
Melanotan-2 (MT-2) is a synthetic derivative of human alpha-melanocyte-stimulating hormone (α-MSH), developed at the University of Arizona in the 1980s. The initial purpose was to create a sunless tanning alternative, inspired by α-MSH's ability to induce sexual arousal and skin darkening in rodents. However, as research progressed, MT-2's diverse effects were unveiled. These include enhancing sexual arousal, promoting skin pigmentation, reducing compulsive behavior, managing addiction, suppressing hunger, decreasing glucagon production, and even potentially reversing certain features associated with autism. Melanotan-2 research has shown it to enhance sexual arousal, promote skin pigmentation through melanocyte activation and reduce compulsive/addictive behaviors.
Reviews
There are no reviews yet.